Zeynep Eroglu

11.0k citations
125 papers · 3.8k · 2 hit papers · h-index 27

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cutaneous Melanoma Detection and Management
    • Colorectal Cancer Treatments and Studies
  • Immunology top 2%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • Cancer Immunotherapy and Biomarkers 36
    • CAR-T cell therapy research 30
    • Cutaneous Melanoma Detection and Management 23
    • Colorectal Cancer Treatments and Studies 7
    • Melanoma and MAPK Pathways 36

Zeynep Eroglu

118 papers receiving 3.8k citations

Zeynep Eroglu's Hit Papers

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab 2016 · 621 citations
6210+3+6Years since publication200400600

Peers

Zeynep Eroglu
Comparison fields: 5 of 94
  • Oncology 2.6k
  • Immunology 872
  • Ophthalmology 243
  • Genetics 204
  • Cancer Research 265
Replace Roxana Dronca with:
Roxana Dronca United States
Salvador Martín‐Algarra Spain
Samra Turajlic United Kingdom
Leslie A. Fecher United States
Lyn M. Duncan United States
Tobias Schatton United States
Hussein A. Tawbi United States
Emanuela Romano France
Wen‐Jen Hwu United States
Adriano Piris United States
Zeynep Eroglu relative to Roxana Dronca United States Roxana Dronca's profile →
Citations per field
00.5×1.5×1.8×
Roxana Dronca · 1×
Citations per year

Countries citing papers authored by Zeynep Eroglu

Since Specialization
Citations

This map shows the geographic impact of Zeynep Eroglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeynep Eroglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeynep Eroglu more than expected).

Fields of papers citing papers by Zeynep Eroglu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeynep Eroglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeynep Eroglu. The network helps show where Zeynep Eroglu may publish in the future.

Co-authors

The 25 scholars most cited alongside Zeynep Eroglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zeynep Eroglu Line = papers co-authored together Zeynep Eroglu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
Hit paper breakdown →
2016621
2 2017298
3
Clinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodies
Hit paper breakdown →
2016277
4 2015234
5 2016208
6 2017177
7 2021140
8 2017130
9 2019115
10 2017106
11 2021103
12 201879
13 202073
14 201567
15 201960
16 201660
17 201960
18 201450
19 201845
20 202143

About Zeynep Eroglu

Zeynep Eroglu is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 125 papers that have together received 3.8k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (36 papers), Cancer Immunotherapy and Biomarkers (36 papers), CAR-T cell therapy research (30 papers), Cutaneous Melanoma Detection and Management (23 papers), Immunotherapy and Immune Responses (19 papers), Brain Metastases and Treatment (9 papers), Cancer Genomics and Diagnostics (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). The work is most often cited by research in Oncology (2.6k citations), Immunology (872 citations), Ophthalmology (243 citations), Genetics (204 citations) and Cancer Research (265 citations). Zeynep Eroglu has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Antoni Ribas, Douglas B. Johnson, Alexander N. Shoushtari, Georgina V. Long, Ryan J. Sullivan, Jeffrey A. Sosman, Katy K. Tsai, Alexander M. Menzies, Vernon K. Sondak and Jonathan S. Zager. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal for ImmunoTherapy of Cancer, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact